Back
Arcus Biosciences Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
51
RCUS
Arcus Biosciences
Last Price:
16.48
Seasonality Move:
7.99%
Sell
21
ITCI
Intra-Cellular Therapies
Last Price:
74.65
Seasonality Move:
0.51%
Buy
51
Arcus Biosciences (RCUS)
is a Buy
Is Arcus Biosciences a Buy, Sell or Hold?
- The current Arcus Biosciences [RCUS] share price is $16.73. The Score for RCUS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- RCUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $75.11. The Score for ITCI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCUS Stock Price Chart
What is Arcus Biosciences's stock price today?
-
The Arcus Biosciences share price today is $16.73
The current trend is moderately bearish and RCUS is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $75.11
The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
RCUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 51.1 | Buy |
Chaikin Money Flow: | -250434 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.96 - 17.7) | Sell |
Bollinger Bands (100): | (14.82 - 16.94) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 53.11 | Buy |
Chaikin Money Flow: | -208488 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.22 - 75.6) | Buy |
Bollinger Bands (100): | (68.18 - 76.66) | Buy |
RCUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.83 | Sell |
20-day SMA: | 17.09 | Sell |
50-day SMA: | 15.89 | Buy |
200-day SMA: | 16.49 | Buy |
8-day EMA: | 16.95 | Sell |
20-day EMA: | 16.75 | Sell |
50-day EMA: | 16.28 | Buy |
200-day EMA: | 16.62 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 74.65 | Buy |
20-day SMA: | 74.17 | Buy |
50-day SMA: | 75.78 | Sell |
200-day SMA: | 70.36 | Buy |
8-day EMA: | 74.7 | Buy |
20-day EMA: | 74.51 | Buy |
50-day EMA: | 74.31 | Buy |
200-day EMA: | 69.75 | Buy |
Arcus Biosciences Earnings Growth & RCUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.38 per share, an increase this year of $0.88 per share, and a decrease next year of $1.09 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Arcus Biosciences Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |